C108H82F20N32O12 — CID 173170752
2,6-difluoro-N-[5-[6-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]benzamide;5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]-N-[4-[[5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]amino]-3-methyl-4-oxobutyl]pyrazine-2-carboxamide;N-[5-[6-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-2-methylpyridine-3-carboxamide;N-[5-[6-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-3-methylpyridine-4-carboxamide;N-[5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]propanamide (PubChem CID 173170752) has the molecular formula C108H82F20N32O12 and a molecular weight of 2400.02 g/mol. Its IUPAC name is 2,6-difluoro-N-[5-[6-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]benzamide;5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]-N-[4-[[5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]amino]-3-methyl-4-oxobutyl]pyrazine-2-carboxamide;N-[5-[6-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-2-methylpyridine-3-carboxamide;N-[5-[6-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-3-methylpyridine-4-carboxamide;N-[5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]propanamide.
| Compound Name | 2,6-difluoro-N-[5-[6-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]benzamide;5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]-N-[4-[[5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]amino]-3-methyl-4-oxobutyl]pyrazine-2-carboxamide;N-[5-[6-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-2-methylpyridine-3-carboxamide;N-[5-[6-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-3-methylpyridine-4-carboxamide;N-[5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]propanamide |
|---|---|
| PubChem CID | 173170752 |
| Molecular Formula | C108H82F20N32O12 |
| Molecular Weight | 2400.02 g/mol |
| Exact Mass | 2398.65 |
| IUPAC Name | 2,6-difluoro-N-[5-[6-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]benzamide;5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]-N-[4-[[5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]amino]-3-methyl-4-oxobutyl]pyrazine-2-carboxamide;N-[5-[6-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-2-methylpyridine-3-carboxamide;N-[5-[6-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-3-methylpyridine-4-carboxamide;N-[5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]propanamide |
| SMILES | CCC(=O)Nc1cnc(-n2c(C(F)(F)F)nc3cc(OC)ccc32)cn1.COc1ccc2c(c1)nc(C(F)(F)F)n2-c1cnc(NC(=O)C(C)CCNC(=O)c2cnc(-n3c(C(F)(F)F)nc4cc(OC)ccc43)cn2)cn1.COc1ccc2nc(C(F)(F)F)n(-c3cnc(NC(=O)c4c(F)cccc4F)cn3)c2c1.COc1ccc2nc(C(F)(F)F)n(-c3cnc(NC(=O)c4cccnc4C)cn3)c2c1.COc1ccc2nc(C(F)(F)F)n(-c3cnc(NC(=O)c4ccncc4C)cn3)c2c1 |
| InChI | InChI=1S/C32H26F6N10O4.C20H12F5N5O2.2C20H15F3N6O2.C16H14F3N5O2/c1-16(27(49)46-24-13-43-26(15-41-24)48-23-7-5-18(52-3)11-20(23)45-30(48)32(36,37)38)8-9-39-28(50)21-12-42-25(14-40-21)47-22-6-4-17(51-2)10-19(22)44-29(47)31(33,34)35;1-32-10-5-6-13-14(7-10)30(19(28-13)20(23,24)25)16-9-26-15(8-27-16)29-18(31)17-11(21)3-2-4-12(17)22;1-11-8-24-6-5-13(11)18(30)28-16-9-26-17(10-25-16)29-15-7-12(31-2)3-4-14(15)27-19(29)20(21,22)23;1-11-13(4-3-7-24-11)18(30)28-16-9-26-17(10-25-16)29-15-8-12(31-2)5-6-14(15)27-19(29)20(21,22)23;1-3-14(25)23-12-7-21-13(8-20-12)24-11-5-4-9(26-2)6-10(11)22-15(24)16(17,18)19/h4-7,10-16H,8-9H2,1-3H3,(H,39,50)(H,41,46,49);2-9H,1H3,(H,26,29,31);2*3-10H,1-2H3,(H,25,28,30);4-8H,3H2,1-2H3,(H,20,23,25) |
| InChIKey | YDNJZVHRZHXEQI-UHFFFAOYSA-N |
| XLogP | 20.56 |
| TPSA | 517.36 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 38 |
| Rotatable Bonds | 26 |
| Heavy Atoms | 172 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2400.02 |
| LogP ≤ 5 | 20.56 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 38 |